In this study, we report on a new method for EV separation using the already established method of size-exclusion chromatography (by using qEV columns from IZON®), followed by immunoprecipitation with CD44-conjugated beads, thereby allowing specific enrichment of glioblastoma-associated EVs from patient serum. The gene discussed is CD44; the disease is glioblastoma.